Faculty, Staff and Student Publications

Language

English

Publication Date

1-1-2024

Journal

Orthopedic Reviews

DOI

10.52965/001c.123443

PMID

39624470

PMCID

PMC11610920

PubMedCentral® Posted Date

9-21-2024

PubMedCentral® Full Text Version

Post-print

Abstract

Purpose of review: Spinal cord stimulation (SCS) is a minimally invasive and reversible therapy for the treatment of severe neuropathic pain. There are several biologic complications that can arise during the implantation of SCS systems. This review aims to consolidate recent research on complications associated with SCS, specifically focusing on biologic complications.

Recent findings: Biologic complications are less frequently encountered compared to device-related complications but may have more severe consequences. Biologic complications covered in this review include infection, seromas, hematomas, dural puncture, nerve/spinal cord injury, and therapy habituation.

Conclusion: The application of SCS remains a viable and effective choice for managing neuropathic pain conditions. It is crucial for physicians to carefully consider potential complications before proceeding with SCS trials and implantation. Familiarity with biologic complications is critical for patient safety and to optimize patient outcomes.

Keywords

Neuromodulation, Spinal Cord Stimulation, Cylindrical Lead, Complications, Epidural Hematoma, Dural Puncture, Post Dural Puncture Headache, Spinal Injury

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.